Selka Health
AI analysis of spine MRI and patient-reported symptoms for clinical trials, healthcare and research
Highlights
- Young companyFounded 2025
- New on EvolcAdded 2026-11-09
About Selka Health
Selka Health develops SpineNet, a deep-learning product that analyses spine MRI and patient-reported symptoms to support patient triage and treatment planning.
Its applications include AI model validation and data analysis for clinical trials, integration of spine MRI insights into MedTech, and bespoke models and support for spinal research.
Selka Health Ltd was founded in 2025 and is headquartered in Thame, United Kingdom.
Product: SpineNet analyses spine MRI and patient-reported symptoms; the company also provides bespoke models and research support.
Jobs at Selka Health
More health & medtech companies
Semble
Practice management and electronic health record software for private healthcare providers and clinicsRemote-friendlySenseiv
Continuous monitoring and alert systems for peripheral IV cannulas, designed for hospitals and clinical staffYoung companyNew on EvolcSensorium
Supplies assistive care technology, nurse-call and bed-management systems to hospitals, care homes and community-care providersNew on EvolcSeptodont
Dental pharmaceuticals and devices for dental and healthcare professionals in the UK and international marketsNew on EvolcSerenity Vets
In-home pet euthanasia and end-of-life care for pet owners in Harlow and surrounding areasYoung companyNew on EvolcSeriderm UK
Aesthetic laser and energy-device distributor supplying physicians and clinics in the UK and IrelandNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- SquarespaceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
